Zobrazeno 1 - 10
of 249
pro vyhledávání: '"Shigeru Kusumoto"'
Autor:
Takuto Tachita, Masaki Ri, Sho Aoki, Arisa Asano, Takashi Kanamori, Haruhito Totani, Shiori Kinoshita, Yu Asao, Tomoko Narita, Ayako Masaki, Asahi Ito, Shigeru Kusumoto, Hirokazu Komatsu, Shinsuke Iida
Publikováno v:
Cancer Medicine, Vol 13, Iss 14, Pp n/a-n/a (2024)
Abstract Multiple myeloma (MM) is an incurable B‐cell malignancy often accompanied by profound immunodeficiency. Lenalidomide (Len) is an immunomodulatory drug that exerts promising therapeutic effects on MM through the immune system. However, pred
Externí odkaz:
https://doaj.org/article/5be8624e698c4954a681a98d8ab053ef
Autor:
Kentaro Hirade, Shigeru Kusumoto, Hiroya Hashimoto, Kazuhide Shiraga, Shinya Hagiwara, Kana Oiwa, Tomotaka Suzuki, Shiori Kinoshita, Masaki Ri, Hirokazu Komatsu, Shinsuke Iida
Publikováno v:
Cancer Medicine, Vol 13, Iss 3, Pp n/a-n/a (2024)
Abstract Background Invasive fungal infections (IFIs) represent a potentially fatal complication in patients who undergo allogeneic hematopoietic stem cell transplantation (HSCT) if the initiation of therapy is delayed. Some guidelines recommend anti
Externí odkaz:
https://doaj.org/article/59d4e532efbd4c6f89adf4d040e51f05
Autor:
Hiromi Hagiwara, Takafumi Nakayama, Hiroya Hashimoto, Shigeru Kusumoto, Hidekatsu Fukuta, Takeshi Kamiya, Koichi Ikuta, Shinsuke Iida
Publikováno v:
Cancer Medicine, Vol 12, Iss 19, Pp 19361-19371 (2023)
Abstract Background Carfilzomib is a selective proteasome inhibitor approved for treating relapsed or refractory multiple myeloma (RRMM). Carfilzomib improves overall survival (OS) and progression‐free survival (PFS); however, treatment with carfil
Externí odkaz:
https://doaj.org/article/18211c8cd7604a2a88d7ac7380485fd7
Autor:
Tomotaka Suzuki, Shigeru Kusumoto, Yoshiko Kamezaki, Hiroya Hashimoto, Nozomi Nishitarumizu, Yoko Nakanishi, Yukiyasu Kato, Akimi Kawai, Naohiro Matsunaga, Toru Ebina, Tomoyuki Nakamura, Yoshiaki Marumo, Kana Oiwa, Shiori Kinoshita, Tomoko Narita, Asahi Ito, Atsushi Inagaki, Masaki Ri, Hirokazu Komatsu, Takashi Aritsu, Shinsuke Iida
Publikováno v:
Cancer Medicine, Vol 12, Iss 12, Pp 13135-13144 (2023)
Abstract Background The recently developed severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) mRNA vaccine has a short history of use and further information is needed regarding its efficacy, especially in immunocompromised conditions,
Externí odkaz:
https://doaj.org/article/250baa990edc4fb8b1c546d09c22e6aa
Autor:
Akiko Nakaoka, Takayasu Nomura, Kazuyoshi Ozeki, Tomotaka Suzuki, Shigeru Kusumoto, Shinsuke Iida, Shinji Saitoh
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 19, Iss 1, Pp 1-4 (2023)
Abstract Background Cases of food allergy after hematopoietic stem cell and solid organ transplantation in previously nonallergic transplant recipients were reported as transplant-acquired food allergy (TAFA), but information about its long-term outc
Externí odkaz:
https://doaj.org/article/c3305fafe5e5421380f46cb5233a64ea
Autor:
Misuzu Fujita, Shigeru Kusumoto, Itsuko Ishii, Tadashi Iwata, Takehiko Fujisawa, Masaya Sugiyama, Akira Hata, Masashi Mizokami
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract There is no universal recommendation for managing the reactivation of HBV in patients with resolved HBV infection treated with anti-CD20 monoclonal antibodies for B-cell non-Hodgkin lymphoma. This study compared the cost-effectiveness of two
Externí odkaz:
https://doaj.org/article/cfd54a82131f49c68166f7fcec5da841
Autor:
Tomotaka Suzuki, Rui Yokomori, Takaomi Sanda, Takaki Kikuchi, Yoshiaki Marumo, Shiori Kinoshita, Tomoko Narita, Ayako Masaki, Asahi Ito, Masaki Ri, Shigeru Kusumoto, Hirokazu Komatsu, Hiroshi Inagaki, Shinsuke Iida
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
We report a 69-year-old female who was a human T-cell leukemia virus type 1 carrier and exhibited a unique clinical course of developing three hematological malignancies within a short period: diffuse large B-cell lymphoma (DLBCL), chronic myelomonoc
Externí odkaz:
https://doaj.org/article/8aba716dd1a04644967bae0b971ebc08
Autor:
Hiroaki Hiramatsu, Kisato Nosaka, Shigeru Kusumoto, Nobuaki Nakano, Ilseung Choi, Makoto Yoshimitsu, Yoshitaka Imaizumi, Michihiro Hidaka, Hidenori Sasaki, Junya Makiyama, Eiichi Ohtsuka, Tatsuro Jo, Masao Ogata, Asahi Ito, Kentaro Yonekura, Hiro Tatetsu, Takeharu Kato, Toshiro Kawakita, Youko Suehiro, Kenji Ishitsuka, Shinsuke Iida, Takaji Matsutani, Hiroyoshi Nishikawa, Atae Utsunomiya, Ryuzo Ueda, Takashi Ishida
Publikováno v:
Haematologica, Vol 108, Iss 4 (2022)
Externí odkaz:
https://doaj.org/article/7a719b715c4f446799368076060e4e23
Autor:
Shinya Hagiwara, Shigeru Kusumoto, Asahi Ito, Ayako Masaki, Kazuhide Shiraga, Takuto Tachita, Kentaro Hirade, Kana Oiwa, Tomotaka Suzuki, Shiori Kinoshita, Masaki Ri, Yasuhiko Ito, Hirokazu Komatsu, Hiroshi Inagaki, Shinsuke Iida
Publikováno v:
eJHaem, Vol 2, Iss 2, Pp 285-290 (2021)
Abstract A 15‐year‐old male was diagnosed with acute myeloid leukemia with t(6;9)(p23;q34), a chimeric DEK‐NUP214 fusion gene. He underwent allogeneic bone marrow transplantation (allo‐BMT) from an unrelated volunteer donor at first molecular
Externí odkaz:
https://doaj.org/article/a35732add6134cf3a015d97342e02613
Autor:
Takafumi Nakayama, Yoshiko Oshima, Shigeru Kusumoto, Junki Yamamoto, Satoshi Osaga, Haruna Fujinami, Takaki Kikuchi, Tomotaka Suzuki, Haruhito Totani, Shiori Kinoshita, Tomoko Narita, Asahi Ito, Masaki Ri, Hirokazu Komatsu, Kazuaki Wakami, Toshihiko Goto, Tomonori Sugiura, Yoshihiro Seo, Nobuyuki Ohte, Shinsuke Iida
Publikováno v:
eJHaem, Vol 1, Iss 2, Pp 498-506 (2020)
Abstract We investigated the incidence of cardiotoxicity, its risk factors, and the clinical course of cardiac function in patients with malignant lymphoma (ML) who received a cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) regime
Externí odkaz:
https://doaj.org/article/87ae7445493b4183952f1ca81d57c702